DebbeMcCall Profile Banner
Debbe McCall Profile
Debbe McCall

@DebbeMcCall

Followers
16K
Following
6K
Media
23K
Statuses
47K

#AFib patient researcher, advocate & DSMB. Digital Editor for JAFIB-EP Journal https://t.co/HGhlTH7n9U @JAFIB_EP on X follow/favorite/tweets ≠ endorse.

California, USA
Joined February 2014
Don't wanna be here? Send us removal request.
@DebbeMcCall
Debbe McCall
7 hours
Hypokalaemia and atrial fibrillation detected by implanted loop recorders https://t.co/NANFrWgj5v
Tweet media one
0
0
0
@DebbeMcCall
Debbe McCall
1 day
Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial https://t.co/fqW9ShN7Yu
Tweet media one
0
1
1
@BetterBiom
biöm
6 months
Ready for a fluoride-free toothpaste that actually works? Introducing NOBS Toothpaste Tablets with just 13 ingredients like nano hydroxyapatite to remineralize enamel & fight sensitivity It’s everything a toothpaste should be, without the BS (get it?)
15
4
34
@DebbeMcCall
Debbe McCall
2 days
Digital twin technology helps reduce the recurrence of atrial arrhythmias after catheter ablation for persistent atrial fibrillation https://t.co/nCiUrquJ3g
Tweet media one
0
0
0
@drraviele
Raviele Antonio
4 days
📌 Progression from paroxysmal to persistent AF 1⃣ Annual incidence 👉 7% 2⃣ Factors that 👉 affect & perpetuate this process #EPeeps #afib #CardioTwitter #MedTwitter @DrJasonAndrade @DhirajGuptaBHRS @PrashSanders @drluissaenz @tomdepotter @cpgale3 @mmamas1973 @DrPascalMeier
Tweet media one
3
36
85
@DebbeMcCall
Debbe McCall
6 days
Tweet media one
0
0
0
@BSCCardiology
BostonSci Cardiology
8 days
LATE-BREAKING CLINICAL DATA: FARADISE real-world global registry highlights the safety and effectiveness of the FARAPULSE™ PFA system in over 1,100 patients. 🔵 1.5% primary adverse event rate 🔵 80.8% 12-month clinical effectiveness in paroxysmal AF See the study:
Tweet media one
0
11
30
@KurtisHanni
Kurtis Hanni
3 months
January Revenue didn’t dip because people stop buying. It dipped because they ran out of inventory. They ran out of inventory because they didn’t have the cash to reload fast enough. You may think you’re in an inventory business or profit business, but in reality you’re in a
23
7
94
@hrs_journal
HeartRhythm
8 days
Catheter Ablation Versus Antiarrhythmic Therapy for Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction https://t.co/RHiikse3Rx
Tweet media one
1
12
41
@Nashwa_Salem_
Nashwa Abdulsalam
8 days
What’s been your observation of pericarditis post-PFA? 🤔 A new study shows rates are similar after PFA and RFA PVI. ▪️ Risk factors: sleep apnea, female sex ▪️ Lower risk: older age, prior ablation ▪️ PFA pericarditis is usually mild, responds to standard therapy, and rarely
@HRS_O2Journal
Heart Rhythm O2
9 days
Risk of acute pericarditis after pulsed-field ablation pulmonary vein isolation, by @julianaperezp25, @tung_patricia, and colleagues @BIDMChealth #EPeeps https://t.co/BNTKIZXhmC
Tweet media one
0
3
9
@DebbeMcCall
Debbe McCall
7 days
Discontinuation of Anticoagulant Therapy After Catheter Ablation for Atrial Fibrillation https://t.co/S8FM7LyEtY
Tweet media one
0
0
1
@DebbeMcCall
Debbe McCall
8 days
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function https://t.co/7MjSyfkHGA
Tweet media one
0
0
0
@jasonnfonsecaa
Jason Fonseca
5 days
Feno Systemic Health Connections
Tweet media one
22
3
145
@drraviele
Raviele Antonio
9 days
Tweet media one
Tweet media two
Tweet media three
2
10
30
@DebbeMcCall
Debbe McCall
9 days
Recent-onset atrial fibrillation: challenges and opportunities https://t.co/0n4BIu1FEJ ' ...is increasingly diagnosed early, close to its first occurrence due to: (i) increased public awareness with self-screening; (ii) health care initiatives including population screening
Tweet media one
0
0
0
@FeliceGragnano
Felice Gragnano
11 days
🚀 PANTHER-2 Clopidogrel monotherapy is superior to aspirin monotherapy for MACCE prevention with no increase in the risk of bleeding in patients with established CAD #ESCCongress 💊 Online 👉 https://t.co/BxwmGa49bo @escardio @vlgmrc @TheLancet #Pharmacotherapy
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
62
171
@hrs_journal
HeartRhythm
11 days
Flecainide in Structural Heart Diseases: A Contemporary Reappraisal Beyond the CAST Trial https://t.co/4fLlVvdReg
Tweet media one
1
39
94
@drraviele
Raviele Antonio
12 days
Tweet media one
Tweet media two
2
35
75
@PrashSanders
Prash Sanders
14 days
🚨HRX Live 2025 starts next week! As a Key Opinion Leader, I’ll be sharing insights with a powerhouse lineup of experts tackling innovative advancements in cardiovascular care. Don’t miss out—grab your pass before it’s too late! #HRX2025
Tweet card summary image
i.snoball.it
I’m attending HRX 2025 in Atlanta on September 4-6! This immersive event brings together innovators in healthcare, AI, and digital health.
0
7
10